ABSTRACT. Authenticating multi-species original raw materials in commercial formulations is difficult. Jin Yin Hua and Shan Yin Hua, both classified as raw honeysuckle materials in the Chinese Pharmacopoeia, are used in various medicines. Differentiating one variety from another is difficult based on chemical analysis. We developed molecular authentication of multi-species original honeysuckle in 3 brands of commercial tablets using allele-specific PCR. All 3 tablets contained both Jin Yin Hua and Shan Yin Hua. We also built a PCR-enzyme digestion method and enzymatic mutation detection in the PCR fragments of psbAtrnH and trnL-trnF, and the restriction endonucleases HinfI and NlaIV, respectively. The PCR-enzyme digestion method produced the same result as the allele-specific PCR. Sequence and phylogenetic analyses show that the tablets YXC and YQJ contained Lonicera japonica and L. macranthoides as original raw materials, and LYG contained L. japonica, L. hypoglauca, and L. macranthoides.
INTRODUCTION
Raw materials are primarily used in producing commercial tablets in Chinese material medicine. The compounds contained in original raw materials consisting of multiple species are different from those in materials composed of a single species. Differences in contents of tablets can be due to the use of different species and can result in different efficacy.
Honeysuckles are used in herbal medicines, and they possess biological and pharmaceutical properties such as anti-bacterial, anti-inflammatory, anti-viral, liver protectant, anti-angiogenic, and anti-nociceptive activities (Ku et al., 2009; Rahman and Kang, 2009; Ryu et al., 2010; Kang et al., 2010) . Five species of honeysuckle, namely, Lonicera (L.) japonica, L. hypoglauca, L. macranthoides, L. confuse, and L. fulvotomentosa , are recorded in the Chinese Pharmacopoeia (Commission, 2010) . Only L. japonica was indicated as Jin Yin Hua, and 4 other species represented Shan Yin Hua (Commission, 2010) . Chlorogenic acid is used in evaluating the chemical quality of these 5 species, and both dipsacoside B and macranthoidin B are used only to evaluate L. hypoglauca, L. macranthoides, L. confuse, and L. fulvotomentosa (Chai et al., 2005; Shang et al., 2011) . However, the similarities in morphological and biochemical characteristics prevent the application of chemical analysis in determining which species are used in producing a commercial tablet (Pu et al., 2002) .
Chloroplast sequences are candidates for species recognition (Kress et al., 2005) . Sun et al. (2011) published the sequences of rbcL, matK, psbA-trnH, and trnL-trnF of L. japonica and its closely related species. We collected and compared 1002 chloroplast sequences of Lonicera Linn. from the GenBank database and obtained 1 SNP (C/A) in trnLtrnF and 2 SNP (G/A, A/T) in psbA-trnH among L. japonica and its 18 closely related species, which include L. hypoglauca, L. macranthoides, L. confuse, and L. fulvotomentosa. Based on the SNP in trnL-trnF, we designed an allele-specific polymerase chain reaction (PCR) method for the molecular authentication of L. japonica medicinal materials (Jiang et al., 2012) .
In this study, we also developed a PCR-enzyme digestion method for the molecular authentication of L. japonica medicinal materials based on the SNP in psbA-trnH. Three types of commercial tablets in Chinese material medicine that contain honeysuckle were initially submitted to molecular authentication using allele-specific PCR and a PCR-RFLP method. trnL-trnF sequences from the DNA of the commercial tablets were analyzed to determine which honeysuckle species were used in producing the tablets.
MATERIAL AND METHODS

Sample collection
Samples of honeysuckle including L. japonica, L. hypoglauca, L. macranthoides, L. confuse, and L. fulvotomentosa were collected from Guangxi, Henan, Shandong, Jiangsu, Beijing, and Anhui Provinces in China. All samples collected were identified by a taxonomist (Table 1) . Three types of tablet samples, namely, Fu Fang Yu Xing Cao Pian, Lin Yang Gan Mao Pian, and Yin Qiao Jie Du Pian, were purchased from different pharmacies (Table 2) .
Genomic DNA extraction and PCR amplification
The genomic DNA was isolated from the sample (25 mg each) using the modified CTAB method (Li et al., 2007) . Total genomic DNA was used in the allele-specific PCR according to the protocol established by Jiang et al. (2012) . PCR was performed by adding 2.5 µL 10X Ex Taq buffer, 2 µL 10 mM dNTPs, 0.5 U Ex Taq (Takara, China), and 10 ng DNA per reaction volume as well as 0.2 pmol of each forward and reverse primer. Total genomic DNA was also used in PCR to amplify trnL-trnF and psbA-trnH from L. japonica and its closely related species, respectively. The universal primers, sequences, and PCR conditions used in the amplification are presented in Table 3 .
Development of the PCR-enzyme digestion method
Sequence assembly and consensus sequence generation were performed using BioEdit v. 7.1.3. The analysis of restriction endonuclease sites was performed using Primer Premier 
Cloning, sequencing, and sequence analysis
The amplified PCR products of psbA-trnH were cloned into pMD19-T vector (Takara, Japan). Ten clones were randomly selected from each sample and directly sequenced at Beijing Genomics Institute, China, using a 3730XL sequencer (Applied Biosystems, USA). Sequence assembly and consensus sequence generation were performed using DNA STAR (Madison, WI, USA). The boundary of the psbA-trnH clones was determined according to the annotations of similar sequences in GenBank. To perform a phylogenetic study, the sequences of the DNA regions were aligned using ClustalW (Thompson et al., 1994) , and the genetic distances were computed using MEGA 5.0 (Tamura et al., 2011) in accordance with the Kimura 2-parameter model.
RESULTS AND DISCUSSION
In recent years, several technologies such as morphology, chemical analysis (Xie et al., 2006) , biological activity assay (Bai et al., 1997; Liu et al., 2006) , and DNA molecular markers (Yip et al., 2007; Al-Qurainy et al., 2011; Guo et al., 2011) have been developed for authenticating raw herbal materials. With their characteristics of non-reliance on morphology, reproducibility, extreme reliability, and easy manipulation, DNA-based molecular tools are urgently needed in authenticating raw herbal materials. Authentication is essential for the standardization of Chinese medicines (Zhao et al., 2006) . Authentication of raw materials is also required for commercial tablets in Chinese material medicine to maintain the quality of these tablets. However, few studies have focused on such molecular authentication. Although many studies have explored the identification of raw honeysuckle using DNA-based molecular tools, such as DNA barcoding (Sun et al., 2011) , PCR-RFLP (Peng et al., 2010) and ITS sequencing (Hu et al., 2012) , they have not focused on how to authenticate honeysuckle in tablets. Coghlan et al. (2012) developed a high-throughput sequencing approach to authenticate the animal and plant composition of 15 traditional commercial Chinese medicine preparations, but this approach was too expensive and time-consuming. In this study, 3 types of commercial tablets containing honeysuckle were purchased from pharmacies and authenticated through the allele-specific PCR method. The results showed that all 3 types of commercial tablet contained L. japonica and its closely related species (Figure 1) . To verify the results, we developed an authentication method based on PCR-enzyme digestion. Based on the SNP (C/A) in trnL-trnF and SNP (G/A) in psbA-trnH between L. japonica and its closely related species, special restriction endonuclease sites, NlaIV and HinfI, were detected in chloroplast sequences of L. japonica. trnL-trnF and psbA-trnH fragments of 165 honeysuckle samples were amplified, and their PCR products were digested by NlaIV and HinfI. The results showed that PCR-NlaIV and HinfI digestion could be used in authenticating L. japonica and its closely related species (Figure 2) . The tablets' PCR fragments amplified by trnL-trnF and psbA-trnH were digested by NlaIV and HinfI, respectively (Figure 3) . The results were similar to those of the allele-specific PCR method. However, aside from L. japonica, other species used in producing commercial tablets could still not be distinguished. Thus, we selected an accepted chloroplast sequence psbAtrnH and obtained a mixed PCR production from the DNA of the tablet. The mixed PCR production was cloned into PMD19-T vector and 10 single PCR clones were randomly selected and sequenced. Honeysuckle species in the tablets were distinguished using sequence and phylogenetic analyses. (Table 4 ).
In conclusion, we suggest that the honeysuckle species L. japonica and L. macranthoides can be used in YXC and YQJ, and L. japonica, L. hypoglauca, and L. macranthoides can be used in LYG. Although these species have similar compositions, they differ slightly in terms of the content of active compounds (Pu et al., 2002; Ren et al., 2008) . The content of chlorogenic acid is lower in L. japonica than in L. macranthoides and L. hypoglauca (Zhou and Tong, 2003; Chen et al., 2005) . However, chlorogenic acid was the only compound used in evaluating the quality of the tablets, and the price of L. japonica was higher than that of other species. Thus, considering the suitable chlorogenic acid content and the production cost, mixed species of original honeysuckle were used in producing the tablets, thus making it difficult to distinguish the species used in these tablets by chemical analysis. Table 4 . BLAST results of honeysuckle in three tablets.
